AKD's practice houses 'a dedicated team of seasoned experts with broad and deep experience in the healthcare industry'. The client roster includes medical associations, healthcare providers, and pharma companies. Practice co-head Joris Rijken is active in contractual work in the healthcare sector, and is equally adept at assisting with care procurement issues. Practice co-head Barbara Mutsaers, who is based in the Eindhoven office, has 'an extremely high level of knowledge of the industry', with a solid track record in handling work concerning clinical trials, marketing authorisations, administrative proceedings and product liability issues. Marlou Jannink is 'precise and dedicated'. Maartje de Jong left the firm in December 2024.
Industry focus: healthcare and life sciences in Netherlands
AKD
Responsables de la pratique:
Joris Rijken; Barbara Mutsaers
Autres avocats clés:
Marlou Jannink
Les références
‘The AKD office offers a full spectrum of services. Communication is very efficient, and the team is very efficient and accurate. ’
‘Barbara Mutsaers has an extremely high level of knowledge of the industry, both commercial as well as legal.’
‘Good knowledge of the market (commercially) and legally; good litigators both on substance and in approach. This appllies in particular to Joris Rijken, who stands his ground professionally and politely. ’
Principaux clients
Utrecht University Medical Centre
Leiden University Medical Centre
Stichting Zuyderland Medisch Centrum
Prinses Máxima Centrum voor Kinderoncologie B.V.
Dutch Association for General Practitioners
Dutch Association for Care for People with a Disability
Dutch Association of Mental Health and Addiction Care
VGZ
Erasmus Medical Center
University Medical Center Utrecht
Maasziekenhuis Pantein B.V.
Stichting Reinier de Graaf Groep
Rode Kruis Ziekenhuis B.V.
Stichting HagaZiekenhuis
Aevitae B.V.
Almende B.V.
OLVG Lab B.V.
Stichting Karakter
BuurtzorgT B.V.
Merz Pharma Benelux B.V.
Alliance Healthcare Nederland B.V.
Vaxxinova International B.V.
Basic Pharma Holding B.V.
Kyowa Kirin Pharma B.V.
Erasmus Universitair Medisch Centrum Rotterdam
ISA Pharmaceuticals
Integris Health
Biomet 3i Netherlands B.V.
Zimmer Dental Inc.
Zimmer Biomet Nederland B.V.
Hestia Cardiovascular Service Center B.V.
Eurocom Healthcare Technology B.V.
Aevitae B.V.
Stichting Zuyderland Medisch Centrum
Principaux dossiers
- Successfully acted for the University Medical Centre Utrecht and the Princess Máxima Centre for Pediatric Oncology in court proceedings concerning heart surgery centres.
- Represented a supplier of veterinary medicines in litigation against the Minister of Agriculture, Nature and Food Quality.
A&O Shearman
A&O Shearman‘s 'extremely responsive, competent, and commercial' team is highly regarded for its ability to handle the full spectrum of contentious and non-contentious issues in the life sciences sector. The group is active on matters in the medtech, biotech, and pharma industries. Practice co-head Frits Gerritzen brings expertise in IP litigation, and is well known for his experience in advising on R&D and license agreements, as well as disputes concerning pharma products, antibodies, and medical equipment. Co-head Christiaan De Brauw specialises in corporate law, and often acts for biotech companies and venture capital entities in M&A and investment work. Jort de Groodt is a key contact for life sciences and technology sector matters.
Responsables de la pratique:
Frits Gerritzen; Christiaan de Brauw
Autres avocats clés:
Jort de Groodt; Sophie Van Asten
Les références
‘Extremely responsive, competent, and commercial. They can be creative and think out of the box to accommodate different situations.’
‘Christiaan De Brauw and Jort de Groodt are a great team: fun to work with, they really seem to care.’
‘Deep knowledge, can do mentality, and pleasant, intelligent professionals!’
Principaux clients
Logex
DSM Firmenich
Leyden Labs
Principaux dossiers
- Advised Thoma Bravo on its acquisition of LOGEX, a Netherlands-based healthcare focused data analytics company.
Hogan Lovells International LLP
Hogan Lovells International LLP‘s 'very proactive and knowledgeable' team has an excellent reputation for advising clients on a broad range of matters, including orphan designations and domestic and international EU regulatory issues. Practice head Hein van den Bos is particularly skilled at advising on regulatory issues involving pharma companies and healthcare professionals, and is equally strong in assisting with EU marketing authorisation applications and data exclusivity and advertising cases. Gertjan Kuipers is 'a stellar litigator', who is noted for his extensive expertise in patent infringement matters and is well known for appearing in disputes before the European Patent Office (EPO) and the Unified Patent Court (UPC). Bert Oosting retired from practice in February 2024.
Responsables de la pratique:
Hein van den Bos
Autres avocats clés:
Gertjan Kuipers; Ruud van der Velden
Les références
‘Gertjan Kuipers stands out as an exceptional talent who consistently demonstrates unmatched expertise, strategic acumen, and unwavering dedication to his clients.’
‘Gertjan Kuipers possesses an extraordinary ability to navigate complex legal landscapes, delivering results that exceed expectations. His in-depth knowledge of the law, coupled with a keen analytical mind, allows him to craft innovative and effective litigation strategies. Gertjan’s courtroom presence is commanding and persuasive, making a significant impact on judges and opposing counsel alike.’
‘Gertjan Kuipers is not only a formidable advocate but also a trusted advisor who prioritises the best interests of his clients. Gertjan’s meticulous preparation and attention to detail ensure that every case is handled with the highest level of professionalism. In summary, Gertjan exemplifies the qualities of a stellar litigator—intelligence, tenacity, and a deep passion for justice.’
Loyens & Loeff
Loyens & Loeff is known for handling a broad range of matters in the healthcare and life sciences arena, including advising on clinical trials, investments, procurement cases and competition issues. Kim Lucassen leads the firm's data protection and privacy practice and is active in life sciences and healthcare matters; she co-heads the department with Vincent van der Lans, a key contact for M&A work and multi-jurisdictional restructurings, and the 'highly skilled' Tom van Helmond, who handles a wide spectrum of procurement and competition law issues. Dieuwke Hooft Graafland's 'knowledge of legislation in her field of expertise is remarkable'. Hamza Zourakhti left the firm in September 2024.
Responsables de la pratique:
Tom van Helmond; Kim Lucassen; Vincent van der Lans
Autres avocats clés:
Dieuwke Hooft Graafland; Aurélie Mingels
Les références
‘Dieuwke Hooft-Graafland’s knowledge of legislation in her field of expertise is remarkable.’
‘Loyens & Loeff provides a high quality of service. The lawyers are specialists in their field.’
‘The team is highly knowledgeable in healthcare and life sciences.’
Principaux clients
AstraZeneca
Zilveren Kruis
Unilabs
Bergman Clinics
Zorgverzekeraars Nederland
European Investment Bank
Forbion
VGZ
Laurens
Unilabs
EQT
Menzis
Amstelland Hospital
Medtronic
Orpea
Galapagos
CZ
PRA International
Orpea
Principaux dossiers
- Advised Eurazeo S.A on the sale of medical technology company DORC to German company Carl Zeiss Meditec AG.
- Advising healthcare insurers on a range of legal matters concerning the bankruptcy of Co-Med.
- Advised the Orpea Group on restructuring and healthcare regulatory aspects in the Netherlands.
BarentsKrans
Based in The Hague, BarentsKrans' 'very dedicated' team often advises on regulatory disputes, sensitive data matters, and public procurement proceedings. Jaap Bremer heads the practice, and is known for his extensive experience in advising on high-value patent litigation in the pharma sector, as well as handling distribution and license agreements. Competition and public procurement expert Tim Raats continues to act for tenderers in mental healthcare and home care matters, and Annelies van der Ploeg is a key contact for M&A and contractual supply issues. Marc Elshof is well versed in advising on cross-border tech, cybersecurity, and data issues.
Responsables de la pratique:
Jaap Bremer
Autres avocats clés:
Tim Raats; Marc Elshof; Annelies van der Ploeg; Koen van Wijk; Jarieke Timmerman
Les références
‘Very dedicated team, comes up with new angles and approaches.’
‘Jaap Bremer and Jarieke Timmerman form a well-oiled machine.’
‘They have good knowledge and can provide new insights and solutions.’
Principaux clients
Viatris
Advance Medical Design
OCRN B.V.
Vivisol Nederland B.V.
Stichting Haaglanden Medisch Centrum
Focus Care Pharmaceuticals
Supergarant Zorg
Advance Medical Designs
Pelvitec
GGZ Noord-Holland-Noord
OCRN B.V.
Vitavanti Healthcare Solutions B.V.
Topa Thermal B.V.
Slimmerik B.V.
Stichting 113
Haaglanden Medisch Centrum
Delft Support
Aenorasis S.A.
Principaux dossiers
- Representing a pharmaceutical company in patent infringement and regulatory litigation regarding a drug for the treatment of multiple sclerosis.
- Assisting Dutch suicide prevention charity Stichting 113 with its privacy compliance needs.
Bird & Bird
The team at Bird & Bird has 'deep legal knowledge combined with a flexible and client-focused approach'. The group is well regarded for it strength in advising on data protection compliance, M&A, large-scale patent infringement cases and exclusivity disputes. Marc van Wijngaarden fields expertise in representing global pharma companies in patent litigation, and co-heads the practice with regulatory expert Hester Borgers, a key contact for digital health matters, and Wilfred Steenbruggen, who handles data work in the healthcare area. Wouter Pors is 'an exceptional advocate', who regularly acts for clients in the biotech industry.
Responsables de la pratique:
Wilfred Steenbruggen; Hester Borgers; Marc van Wijngaarden
Autres avocats clés:
Wouter Pors; Chloe Verschoor; Pauline Vos
Les références
‘The Bird&Bird team are pragmatic.’
‘Hester Borgers is a valuable member of the team. Hester is able to seamlessly manage regulatory advice across jurisdictions and has a client-first approach. She inherently understands what is important to our business, and is very solutions-focused in her advice.’
‘Very practical advice, given their in-depth understanding of the complex laws and regulations that apply to the life sciences industry and the variations at the country level.’
Principaux clients
B Braun Melsungen
Fengh Medical
Oculentis
ConvaTec
Polpharma
Sanofi & subsidiary Ablynx
Bicycle Therapeutics
Edwards Lifesciences
Chinook
Lonza Group
Veloxis Pharmaceuticals
Preceyes
Odysight AI
Pet Service Holding
Neuraxpharm
Dexcom
Principaux dossiers
- Representing Neuraxpharm in patent litigation in the Netherlands against Biogen.
- Assisted Calypso Biotech and its shareholders with the sale of Calypso to Novartis Pharma AG.
- Advising Teva on various data protection compliance matters.
CMS
Ellen Gielen and Gertie Lintjens jointly head CMS‘ practice, which is known for advising on M&A, contentious reimbursement matters, and pricing negotiations. The 'very knowledgeable' Gielen has extensive experience in handling regulatory cases, often involving pharmaceutical and medical device issues, while Lintjens is well versed in handling R&D projects and early access matters involving pharma products. Judith Kok has a solid track record in assisting with biocides matters and distribution issues. Murat Duman joined the group in January 2024.
Responsables de la pratique:
Ellen Gielen; Gertie Lintjens
Autres avocats clés:
Judith Kok; Renate Bik; Murat Duman
Les références
‘One of the most broad life sciences teams in the Netherlands covering all aspects of life sciences.’
‘Ellen Gielen has seen it all and thus has both the professional knowledge to help clients achieve their goals as well as the gravitas to guide you there.’
‘Ellen Gielen is great and very knowledgeable. I also enjoy working with Judith Kok.’
Principaux clients
Amgen
Boston Scientific
Brocacef
Carl Zeiss
Eli Lilly
Essity
Johnson & Johnson
LEO Pharma
Mölnlycke Health Care
Netherlands Cancer Institute
Nordmark Pharma GmbH
Pharming Group N.V.
Sanquin
Stryker
Thermo Fisher
Vivus
Principaux dossiers
- Represented Eli Lilly in litigation concerning reimbursement of its breast cancer treatment Verzenios.
- Advised Carl Zeiss Meditec AG on its agreement to acquire DORC from investment firm Eurazeo SE for EUR 985 million.
- Advising Boston Scientific on the development of a logistics center in the Netherlands.
De Brauw Blackstone Westbroek
At De Brauw Blackstone Westbroek, the team is well known for appearing before the Dutch Supreme Court in patent cases, and is equally strong in handling investment and refinancing matters. Anne Marie Verschuur and Gaby Smeenk co-head the practice; the former is well versed in handling matters concerning trade secrets, as well as infringement and validity proceedings, while the latter assists with M&A and capital markets transactions. Bertrand Ter Woort is a key contact for medical device and pharma clients, and Stephanie de Beer has established strength in handling patent validity and infringement disputes.
Responsables de la pratique:
Anne Marie Verschuur; Gaby Smeenk
Autres avocats clés:
Bertrand ter Woort; Tobias Cohen Jehoram; Stephanie de Beer
Principaux clients
Advanced Bionics
Affimed N.V.
Almirall B.V.
AmyriAD Therapeutics
Biogen
Bristol Myers Squibb
Byondis
Corbion
Duomed
Eli Lilly
Ferring
Forbion
G Square
GSK
Koninklijke Philips N.V.
Koppert
Pharmathen
Qiagen
Synthon Holding B.V.
Triton Investment Management Limited
UMCG
Waterland
Zimmer Biomet
Principaux dossiers
- Representing Bristol Myers Squibb in patent proceedings against Sandoz and Teva before the Dutch Supreme Court.
- Representing GSK in patent litigation.
Houthoff
Houthoff‘s practice, which is jointly led by Huib Lebbing and Freeke Heijne, is well known for representing the Ministry of Public Health and other prominent clients in a wide range of healthcare and hospital-focused matters. Lebbing is 'very knowledgeable, with a highly developed analytical mind', and Heijne draws on her public law expertise to advise healthcare providers, insurers, and investors on civil proceedings. Murat Duman left the firm in January 2024.
Responsables de la pratique:
Huib Lebbing; Freeke Heijne
Autres avocats clés:
Weijer VerLoren van Themaat
Les références
‘Huib Lebbing is very knowledgeable, with a highly developed analytical mind.’
‘An excellent knowledge of the relevant sector, the applicable law and the sensitivities that relate to a case.’
Principaux clients
Amsterdam UMC
Bergman Clinics
Equipe Zorgbedrijven
ZKN
GIMV
Leger des Heils
ONVZ
The Ministry of Public Health
William Schrikker Groep
Ottobock
Zorgservice XL
Principaux dossiers
- Representing Novartis in patent litigation before the Dutch Supreme Court against Mylan.
- Defending the Ministry of Public Health, Welfare and Sport against claims for damages brought by the Dutch Trade Union Confederations FNV and CNV on behalf of several healthcare workers.
- Advising FDI B.V., a Dutch investment fund, on the acquisition of Intravacc from the Ministry of Health.
NautaDutilh
The practice at NautaDutilh has a solid track record in acting for pharma clients in a broad range of work, including transactional matters, patent proceedings and class action claims relating to medical devices. The 'exceptionally insightful' Ruud Smits is active in transactional work, and advises medical device, pharma, and biotech start-ups and investors on financing matters. Smits co-heads the department with Jeroen Boelens, a key contact for licensing and M&A issues, as well as multi-jurisdictional patent disputes. Paul van der Bijl is a name to note.
Responsables de la pratique:
Ruud Smits; Jeroen Boelens
Autres avocats clés:
Paul van der Bijl; Joppe Schoute; Lauren Delleman
Les références
‘Ruud Smits kept a clear view on the important issues from a client perspective, and was very business minded.’
‘Paul van der Bijl is exceptionally insightful, efficient and pragmatic. He’s focused on solutions and de-complexifying.’
‘The practice has in-depth knowledge.’
Principaux clients
Forbion
NewAmsterdam Pharma
Pharvaris
GSK
Adcytherix
Avania
EQT Life Sciences
The Protein Brewery
Lumicks
Mimetas
Onera Health
Galenicum
Pharming Group
Principaux dossiers
- Advised a consortium of investors, led by Forbion and EQT Life Sciences, on the EUR 129m Series A investment round of VectorY Therapeutics B.V.
- Acted as lead counsel to Pharming on its issuance of EUR 100 million senior unsecured convertible bonds due 2029.
- Represented Galenicum Health in patent litigation against Insud Pharma.
Simmons & Simmons
Johan Renes, Bas Berghuis van Woortman, and Machteld Hiemstra co-head the practice at Simmons & Simmons, which is well-known for its strength in patent litigation. Renes has longstanding experience in multi-jurisdictional patent disputes, licensing matters and collaboration agreements. Hiemstra is a key name for representing pharma and biotech entities in regulatory and product liability disputes, and van Woortman is noted for his vast experience in representing biosimilar manufacturers in patent-related work. Oscar Lamme is well-versed in assisting with UPC proceedings.
Responsables de la pratique:
Johan Renes; Bas Berghuis van Woortman; Machteld Hiemstra
Autres avocats clés:
Oscar Lamme; Sebastien Versaevel; Daisy Termeulen
Principaux clients
Alnylam
Alcon
GlaxoSmithKline
Wright Medical
Eli Lilly
Gilead Sciences
Lundbeck
Terumo
Coloplast
Netherlands Cancer Institute
Bayer Healthcare
Samsung Bioepis
DC Prime
Seattle Genetics Inc.
Sint Maartenskliniek
Medicxi
Align Technology
Serenity Pharmaceuticals
Médecins sans frontiers
Unicef
Zimmer Biomet
Maastricht University Medical Centre+
Plant-e
Rhythm
Avanzanite
UCB
Med-El
Principaux dossiers
- Represented Bayer HealthCare in proceedings against Sandoz and Teva concerning the drug Xarelto.
- Represented Plant-e in infringement proceedings at the UPC in the Netherlands.
- Representing Bayer BV in matters concerning clinical trial information, in relation to patent disputes concerning Xarelto.
Van Doorne
Van Doorne's 'outstanding team of expert lawyers' is very experienced in digital health matters. Willemien Bischot acts for healthcare providers and academic hospitals in a range of corporate matters, as well as assisting elderly and special needs providers; she co-heads the practice with the 'excellent' Dimitri van Hoewijk, who regularly acts as counsel to healthcare institutions. Other key figures restructuring and acquisitions expert Siego Boslooper; Nick Suurmond, who handles joint ventures and investments; and tax specialist Daniëlle Westerhoff.
Responsables de la pratique:
Willemien Bischot; Dimitri van Hoewijk
Autres avocats clés:
Nick Suurmond; Daniëlle Westerhoff; Siego Boslooper
Les références
‘The team can make complicated issues simple. A clear overview of the pros and cons and objective advice about the different options.’
‘Van Doorne’s unique approach, which combines a broader perspective, multi-disciplinary strategy, and collaboration, sets them apart in the legal industry. They are a valuable partner for any client in the healthcare sector. Van Doorne considers the wider implications for their clients. This holistic approach allows them to craft solutions that are legally sound and strategically smart. Van Doorne believes in collaboration within their team and with clients. This leads to more effective and innovative solutions. Clients benefit from this approach, experiencing how teamwork leads to superior outcomes. ’
‘Willemien Bischot truly stands out.’
Principaux clients
Arthrex GmbH
Arthrex Nederland B.V.
Belmont Instrument, LLC
Veonet GmbH
Stichting Kinderen Kankervrij
Link Nederland B.V.
OM Pharma SA
Symeres Netherlands B.V.
QurAlis Netherlands B.V.
Lumanity
Erasmus MC
Mentaal Beter
Gelre Ziekenhuizen
Albert Schweitzer Ziekenhuis
Ksyos
Amsterdam UMC
emeis
Buurtzorg
ZRTI
Mediq
NKI/AVL
Amerpoort
Navitas
NPM Capital
Zaans Medisch Centrum
Domus Valuas
Rijnstate
Interakt Contour
GGZ Eindhoven
GGZ InGeest
Principaux dossiers
- Advised Amerpoort and Sherpa on their merger.
- Advised a consortium of 20 healthcare providers, together with investment fund IFOZ, on collaboration and investment in CB Healthcare, an platform for the ordering, logistics and delivery of medical instruments.
- Represented Medux in proceedings against various healthcare insurance companies regarding a tariff dispute.
Dirkzwager legal & tax
Dirkzwager legal & tax is perhaps best known for its strong track record in acting for hospitals in the Netherlands in a broad range of healthcare-related matters. Koen Mous is well-versed in handling claims against health insurers, in addition to healthcare contracts, while Marieke van Dongen‘s primary areas of expertise include M&A, restructurings, and governance issues within the healthcare space. Ernst-Jan van de Pas specialises in advising hospitals on IT and tech procurement issues. Louis Houwen is a key contact for hospitals and health providers, and Luuk Arends often represents mental health and elderly care providers. All named practitioners co-head the practice.
Responsables de la pratique:
Koen Mous; Marieke van Dongen; Ernst-Jan van de Pas; Louis Houwen; Luuk Arends
Autres avocats clés:
Stefan Donkelaar
Les références
‘Besides the in-depth knowledge of the healthcare market, Dirkzwager’s healthcare team performs exceptionally well in translating their legal knowledge in practical solutions. These solutions are often found outside the legal domain, which has proven to be beneficial for the relationship with parties involved.’
‘I had the privilege of working with Koen Mous and Stefan Donkelaar, and I can confidently say that they are exceptional attorneys. Their deep understanding of the Dutch healthcare landscape, coupled with their strategic thinking, made a significant difference in the outcomes. I would highly recommend Koen Mous and Stefan Donkelaar to anyone in need of legal representation. Their expertise, dedication, and commitment to their clients are truly commendable.’
‘Dirkzwager has a good healthcare team. They have a strong profile on corporate governance and corporate law in health care (and other state regulated sectors).’
Principaux clients
Sint Maartenskliniek
Deventer Ziekenhuis
ETZ
Rijnstate Ziekenhuis
Landelijke Huisartsen Vereniging
Pluryn
NVZ Nederlandse Vereniging van Ziekenhuizen
Bravis Ziekenhuis
Oogziekenhuis Rotterdam
Pro Persona
Abrona
Archipel
Stichting Revalidatiegeneeskunde Nederland
Principaux dossiers
- Advised academic hospital MUMC+ on its collaboration with hospital SJG Weert.
- Represented 18 footcare healthcare providers in proceedings against a major health insurer.
- Advised on the partnership between mental health provider Pro Persona, addiction rehabilitation centre IrisZorg and Hospital Rivierenland.
Kennedy Van der Laan
Kennedy Van der Laan's practice houses 'an involved team with broad and excellent knowledge'. The group is well versed in handling the full spectrum of transactional issues within the healthcare sector. Practice co-head Fenna van Dijk draws on her corporate law expertise to assist healthcare institutions and medical device suppliers, while co-head Maarten Schut has longstanding experience in assisting with R&D collaborations and license agreements. Other key practitioners include Eline Lam, who advises on collaboration matters in the healthcare sector, and Anne ten Brummelhuis, who counts tariff regulation as a key area of strength.
Responsables de la pratique:
Fenna van Dijk; Maarten Schut
Autres avocats clés:
Eline Lam; Anne ten Brummelhuis
Les références
‘An involved team with broad and excellent knowledge. Easy to approach and very committed to the client needs.’
‘Fenna van Dijk is a wonderful professional to work with. She shares a wealth of knowledge and experience and is truly dedicated in advancing the goals and needs of our organisation.’
‘Collaboration and openness to reflection.’
Principaux clients
Aidsfonds
Ambulance Amsterdam
Andros Clinics
Arkyne Technologies
Arts en Zorg
GezondheidsZorg Asielzoekers Nederland B.V.
Certis Europe
Gadeta
GGD Amsterdam
GGD GHOR
LCCB
GGZ inGeest
GITP
GLIA
Heliomare
Huisartsenposten Rijnmond
HVO-Querido
Intravacc
Landelijke Huisartsenvereniging
MediRisk
Nutreco
Odion
Oncode Institute
Oncode Accelerator
Polaroid Therapeutics
Reinier Haga Medisch Diagnostisch Centrum
Stichting Kinderoncologie Nederland
Syngenta
VECOZO
Vivium Zorggroep
University of Amsterdam Medical Center
Principaux dossiers
- Advised the board of managing directors of Intravacc on the sale of the company by the Department of Healthcare to First Dutch Innovations.
- Assisted Reinier de Graaf Hospital with the set up of a long-term collaboration with a group of gynecologists, in order to set up a specialist endometriosis treatment center.
- Represented Amsterdam UMC in litigation against former employees who sold a diagnostics start-up to US gene-tech giant Illumina Inc.
La Gro
La Gro's practice has vast experience in assisting with the corporate restructuring of healthcare entities and UPC infringement proceedings. Practice head Marleen van den Horst is well known for handling SPC and regulatory issues, and often acts for large pharmaceutical companies in matters concerning clinical trials and orphan medicinal products. Benjamin Niemeijer has expertise in IP litigation, and often assists healthcare providers with tech-related transfers.
Responsables de la pratique:
Marleen van den Horst
Autres avocats clés:
Benjamin Niemeijer; Iris Arts
Les références
‘The team are very knowledgeable and great to work with. Very reliable.’
‘Pleasant personal attention, capable of providing timely suitable solutions.’
‘Benjamin Niemeijer is knowledgeable and truly cares for his clientele, and is able to provide the correct input needed to make good decisions and to make the process seamless.’
Principaux clients
Stichting Alrijne Zorggroep
Insud Pharma
Leiden University Medical Center
Move the Brain
Oldelft Ultrasound
Stada Arzneimittel
Adalvo
Focus Care Pharmaceuticals
Amgen
OrthoApnea
Vivisol B
NeoKidney Foundation
Pharming Group
European Society for Immunodeficiencies
The Netherlands Center for the Clinical Advancement of Stem Cell and Gene Therapies
Principaux dossiers
- Represented Amgen in biosimilar patent litigation.
- Represented Insud Pharma in invalidity proceedings concerning pharmaceutical patents.
- Representing OrthoApnea and Vivisol B in patent infringement proceedings.
Maverick Advocaten N.V.
Competition law boutique Maverick Advocaten N.V. has an established track record in representing mental health care entities, medical device companies, and GPs before the Dutch Healthcare Authority, often in litigation relating to public procurement. Diederik Schrijvershof has a strong focus on healthcare sector mergers and procurement issues, and Martijn van de Hel is well known for advising on state aid issues and investigations by the Netherlands Authority for Consumers and Markets (ACM); the duo co-head the practice with Cyriel Ruers. Annabel Kingma and Leah Peeters are names to note.
Responsables de la pratique:
Diederik Schrijvershof; Martijn van de Hel; Cyriel Ruers
Autres avocats clés:
Annabel Kingma; Leah Peeters
Les références
‘They have unique knowledge in the field of competition law. They are specialists, just the best.’
‘Experienced, no nonsense, dedicated, trustworthy and just doing what they have to do.’
‘Maverick is an office with a very clear industry expertise but especially a mindset on being practical in a getting things done kind of way. They are very clear on risks, percentages and thinking through steps ahead. This makes working with them practical and very clear.’
Principaux clients
Actiz
Asker
Mediq
Chipsoft
Z-index
Stichting Frion
Stichting STAR-SHL
De Bevlogen Huisartsen
Stichting De Forensische Zorg Specialisten
Pluryn
Radboud UMC
ZorgDomein
Leiden University Medical Centre
NVOS-Orthobanda
Parnassia Groep
De Nederlandse GGZ
Erasmus MC
Baalderborg
Bayer
Amsta
Revalidatie Friesland
Trajectum
Fivoor
Medipoint
Fmed
Nederlandse Vereniging van Ziekenhuizen NVZ
Maasstad Ziekenhuis
Reinier De Graaf Groep
Noordwest Ziekenhuisgroep
Yulius
Trubendorffer
GGZ Friesland
FMed
Huisartsen Groep Eendracht
ARQ
Principaux dossiers
- Represented STAR-SHL in appeal proceedings relating to the selective 2024 and 2025 primary care diagnostics procurement policy of health insurer Zilveren Kruis.
- Represented the De Bevlogen Huisartsen (DBH) foundation and over 100 individual GPs before the Trade and Industry Appeals Tribunal regarding the 2023 Performance and Rate Decision on GP care and multidisciplinary care.
- Represented seven mental health care providers in a challenge to a procurement policy.
Pels Rijcken & Droogleever Fortuijn NV
Pels Rijcken & Droogleever Fortuijn NV's team earns plaudits for its 'profound knowledge of the healthcare sector'. The practice is sought after by Dutch governmental entities, healthcare insurance companies and healthcare providers. Practice co-head Wemmeke Wisman is well versed in advising on international public law disputes, often relating to rights to medical treatment, while co-head Marije Batting advises on the reimbursement, approval, and pricing of medicinal products. Co-head Elisabeth Pietermaat is highly regarded for her regulatory expertise.
Responsables de la pratique:
Wemmeke Wisman; Marije Batting; Elisabeth Pietermaat
Autres avocats clés:
Jorrit van de Weide; Paul Tanja
Les références
‘The firm has a large and experienced healthcare team. The team has profound knowledge of the healthcare sector which makes them the key advisor to go to.’
‘The team are always available when we’re in need of help. And the help given by the team is very knowledgeable and appreciated.’
‘I would like to especially mention Paul Tanja and Wemmeke Wisman and their teams. They are sharp as a knife, on time with advice, superb sparring partners and fun too.’
Principaux clients
Nederlandse Zorgautoriteit
IGJ
CZ
Menzis
VGZ
Zorgverzekeraars Nederland
Zorginstituut Nederland
The State of the Netherlands (Ministry of Health, Welfare and Sport)
The State of the Netherlands (Ministry of Defence)
Florence
CBG
Zilveren Kruis
Domus Magnus
Stichting Cordaan
Principaux dossiers
- Representing the Dutch Healthcare Authority in a dispute over the reimbursement of mental health care for the years 2022 and 2023.
Pinsent Masons LLP
At Pinsent Masons, the practice is very experienced in advising on IP matters in the life sciences sector. Patent disputes are prominent in the group's workload, and the team has been kept busy assisting pharma and biotech clients with market authorisation matters. Practice head Judith Krens is well versed in advising on multi-jurisdictional SPC and patent litigation, and Arjan Reijns acts on disputes concerning generic product launches.
Responsables de la pratique:
Judith Krens
Autres avocats clés:
Arjan Reijns; Marthe Riewald
Les références
‘Knowledgeable and efficient team.’
‘Expert advice and quick service.’
‘Good experience and knowledge.’
Principaux clients
Teva Pharmaceutical Industries Limited
Advanced Cell Diagnostics Inc.
Accord Healthcare Limited
Fresenius Kabi
Torrent Pharmaceuticals
Napiferyn Biotech
Lotus Pharma
Bioeq
Sun Pharma
Principaux dossiers
- Representing Teva in regulatory litigation concerning market exclusivity for Tecfidera.
- Representing Teva in proceedings before several courts in the Netherlands concerning the drug apixaban.
- Representing a generic pharma company in administrative proceedings concerning validity issues.
Rutgers & Posch
Under the leadership of Anouk Jagt, the team at Rutgers & Posch is perhaps best known for its strength in advising on professional disciplinary matters and transactional work in the healthcare sector. Dirk Jan Rutgers is a key contact for employment law matters, and Jeanne Plettenburg is very experienced in assisting with procurement and collaborations in the healthcare space.
Responsables de la pratique:
Anouk Jagt
Autres avocats clés:
Jeanne Plettenburg; Dirk Jan Rutgers; Matthijs van den Broek
Les références
‘I feel respected, appreciated, and it feels like we are working together on solutions. The advice is of a high standard.’
‘The team works well together and is well coordinated. They translate legal advice into practice.’
‘Very knowledgeable. Know the relevant laws and regulations as would be expected. Businesslike, but with an eye for sensitivities.’
Principaux clients
SJG Weert B.V.
Luscii Healthtech
Hoya Holdings N.V.
Principaux dossiers
- Advised the shareholders of Luscii Healthtech on the sale of the company to Omron Healthcare.
- Advised on the acquisition of St. Jans Gasthuis Weert hospital by academic hospital Maastricht UMC+.
- Advising Hoya Corporation on the acquisition of Wassenburg Medical B.V.
Taylor Wessing
The team at Taylor Wessing is noted for its expertise in handling UPC issues and infringement actions for clients in the medical device and pharma industries. Regulatory work is another core area of strength for the group. Charlotte Garnitsch is known for her experience in advising on patent infringement proceedings; she co-heads the practice with Eelco Bergsma and Wim Maas. Margot van Gerwen primarily advises pharma companies on trade mark, advertising and copyright issues.
Responsables de la pratique:
Charlotte Garnitsch; Eelco Bergsma; Wim Maas
Autres avocats clés:
Margot van Gerwen
Principaux clients
Pfizer
Abbott
Tandem Diabetes Care
Glenmark
Fresenius
Principaux dossiers
- Defended Pfizer against two infringement actions brought against the client by Moderna.
- Acting for Abbott in multi-jurisdictional patent litigation against Dexcom regarding continuous glucose monitoring (CGM) devices.
- Advising Tandem Diabetes Care on multiple UPC actions brought against F.Hoffman-La Roche AG and Roche Diabetes Care.